BioXcel Therapeutics, Inc. (BTAI)
NASDAQ: BTAI · Real-Time Price · USD
1.730
+0.250 (16.89%)
At close: Mar 9, 2026, 4:00 PM EDT
1.700
-0.030 (-1.73%)
After-hours: Mar 9, 2026, 7:58 PM EDT
BioXcel Therapeutics Market Cap
BioXcel Therapeutics has a market cap or net worth of $37.83 million as of March 9, 2026. Its market cap has increased by 520.23% in one year.
Market Cap
37.83M
Enterprise Value
107.88M
1-Year Change
520.23%
Ranking
Category
Stock Price
$1.73
Market Cap Chart
Since March 8, 2018, BioXcel Therapeutics's market cap has decreased from $167.60M to $37.83M, a decrease of -77.43%. That is a compound annual growth rate of -16.98%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 6, 2026 | 32.40M | -7.43% |
| Dec 31, 2025 | 35.00M | 118.75% |
| Dec 31, 2024 | 16.00M | -81.48% |
| Dec 29, 2023 | 86.40M | -85.65% |
| Dec 30, 2022 | 601.90M | 5.82% |
| Dec 31, 2021 | 568.80M | -49.48% |
| Dec 31, 2020 | 1.13B | 327.25% |
| Dec 31, 2019 | 263.50M | 336.26% |
| Dec 31, 2018 | 60.40M | -63.96% |
View and export this data all the way back to 2018.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Assertio Holdings | 74.60M |
| Incannex Healthcare | 50.52M |
| Cumberland Pharmaceuticals | 50.25M |
| InterCure | 47.51M |
| Talphera | 41.36M |
| SCYNEXIS | 38.41M |
| Rockwell Medical | 35.57M |
| Zhengye Biotechnology Holding | 35.54M |